Henry Schein, Inc. (HSIC)
Nasdaq: HSIC · Wholesale-Medical, Dental & Hospital Equipment & Supplies · Melville, NY · filing with the SEC since 1996
Grade5.4
◀ Past 5.2● Present 5.4▶ Future 5.4
Who owns Henry Schein, Inc.
As filed with the SECHolders of 5% or more
4
KKR Group Partnership L.P. holds 16.4% of Common Stock, par value $0.01 per share, as its SCHEDULE 13D/A filed Mar 10, 2026 says.
Directors and officers
21
report now, of 48 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
KKR Group Partnership L.P.
SCHEDULE 13D/A · filed Mar 10, 2026 · Common Stock, par value $0.01 per share · 15.2% in Dec 9, 2025
Fmr LLC
SCHEDULE 13G · filed Aug 6, 2026 · COMMON STOCK
Vanguard Capital Management
SCHEDULE 13G · filed Apr 30, 2026 · Common Stock
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 17, 2025 · Common Stock
JPMorgan Chase & Co.
SCHEDULE 13G/A · filed Oct 31, 2025 · Common Stock, par value $.01 per share · reported falling below 5%, from 5% in Apr 25, 2025
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%, from 10.2% in Dec 3, 2025
What HSIC reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Shield Healthcare, Inc.
A company bought · acquisition · Sep 2023 · owns, named in the 10-K filed Feb 24, 2026
S.I.N. Implant System
A company bought · acquisition · Jun 2023 · owns, named in the 10-K filed Feb 24, 2026
Biotech Dental
A company bought · acquisition · Mar 2023 · owns, named in the 10-K filed Feb 24, 2026
TriMed, Inc.
A company bought · acquisition · owns, named in the 10-K filed Feb 24, 2026
35 subsidiaries in 1 country, from the list filed with the 10-K filed Feb 24, 2026.
Insider tradesForm 4
10sales
1purchases
0sales on a scheduled plan
5people selling
$8.6Msold, in dollars
$700,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window6 of 68 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Bergman Stanley M | Chairman, CEO | 5 | $7.5M | 0 | 0 | $0 |
| Mlotek Mark E | EVP, Chief Strategic Officer | 2 | $500,000 | 0 | 0 | $0 |
| Kuehn Kurt P | director | 1 | $200,000 | 0 | 0 | $0 |
| Laskawy Philip A | director | 1 | $200,000 | 0 | 0 | $0 |
| Popeck Thomas C | CEO, Henry Schein Products | 1 | $100,000 | 0 | 0 | $0 |
| Daniel William K | director | 0 | $0 | 0 | 1 | $700,000 |